MiR-495 Inhibits the Growth of Fibroblasts in Hypertrophic Scars

Overview

Journal Aging (Albany NY)

Specialty Geriatrics

Date 2019 May 16

PMID 31085805

Citations 14

Authors

Bingyu Guo

Qiang Hui

Zhishan Xu

Peng Chang

Kai Tao

Affiliations

Soon will be listed here.

Abstract

Noncoding RNAs are known to be importantly involved in a variety physiological and pathophysiolgical processes. Their role in the pathogenesis of hypertrophic scars remains unclear, however. After preliminary screening of the microRNA (miRNA) gene expression profiles, we explored the role of miR-495 in the development of hypertrophic scar by comparing expression of miR-495 and focal adhesion kinase (FAK) between hypertrophic scar and normal skin tissue. We also used 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide and annexin V-fluorescein isothiocyanate/propidium iodide assays to assess the effect of miR-495 on the proliferation and apoptosis in human hypertrophic scar fibroblasts. Western blotting and real-time polymerase chain reaction were used to evaluate expression of miR-495, FAK, and related proteins in the FAK pathway. Our findings show that miR-495 inhibits FAK and its downstream mediators in vitro and vivo, and suggest that miR-495 may be a useful therapeutic target for the treatment of hypertrophic scar.

Citing Articles

The potential role of miRNAs and regulation of their expression in the development of mare endometrial fibrosis.

Wojtowicz A, Molcan T, Lukasik K, Zebrowska E, Pawlina-Tyszko K, Gurgul A Sci Rep. 2023; 13(1):15938.

PMID: 37743390 PMC: 10518347. DOI: 10.1038/s41598-023-42149-3.

[Research advances on the role and mechanism of microRNA in hypertrophic scar].

Tian W, Zuo J, Ai J, Qi Y, Bu P, Zhao J Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2023; 39(2):196-200.

PMID: 36878530 PMC: 11630454. DOI: 10.3760/cma.j.cn501225-20220508-00179.

Mechanisms underlying pathological scarring by fibroblasts during wound healing.

Ma Y, Liu Z, Miao L, Jiang X, Ruan H, Xuan R Int Wound J. 2023; 20(6):2190-2206.

PMID: 36726192 PMC: 10333014. DOI: 10.1111/iwj.14097.

Is the future scarless? - Fibroblasts as targets for scarless wound healing: a narrative review.

Parry D, Allison K Scars Burn Heal. 2022; 8:20595131221095348.

PMID: 36082315 PMC: 9445533. DOI: 10.1177/20595131221095348.

The current landscape of microRNAs (miRNAs) in bacterial pneumonia: opportunities and challenges.

Zhang F, Zhou Y, Ding J Cell Mol Biol Lett. 2022; 27(1):70.

PMID: 35986232 PMC: 9392286. DOI: 10.1186/s11658-022-00368-y.

References

Li Z, Cao Y, Jie Z, Liu Y, Li Y, Li J . miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3. Cancer Lett. 2012; 323(1):41-47. DOI: 10.1016/j.canlet.2012.03.029. View

Lee S, Jung Y, Choi Y, Lee Y . Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells. Oncotarget. 2015; 6(32):33269-78. PMC: 4741764. DOI: 10.18632/oncotarget.5037. View

Qiang Y, Li C, Sun R, Zheng L, Peng L, Yang J . Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling. J Exp Clin Cancer Res. 2018; 37(1):34. PMC: 5819171. DOI: 10.1186/s13046-018-0692-8. View

Liu F, Chen W, Li Y, Zhang J, Zheng Q . MiR-6836-3p promotes proliferation of hypertrophic scar fibroblasts by targeting CTGF. Eur Rev Med Pharmacol Sci. 2018; 22(13):4069-4074. DOI: 10.26355/eurrev_201807_15396. View

Clark A, Maruyama S, Sano S, Accorsi A, Girgenrath M, Walsh K . miR-410 and miR-495 Are Dynamically Regulated in Diverse Cardiomyopathies and Their Inhibition Attenuates Pathological Hypertrophy. PLoS One. 2016; 11(3):e0151515. PMC: 4801331. DOI: 10.1371/journal.pone.0151515. View

Zhang Y, Lin X, Zhang L, Hong W, Zeng K . MicroRNA-222 regulates the viability of fibroblasts in hypertrophic scars via matrix metalloproteinase 1. Exp Ther Med. 2018; 15(2):1803-1808. PMC: 5776557. DOI: 10.3892/etm.2017.5634. View

Zhang P, Wang W, Wang X, Wang X, Song Y, Zhang J . Focal adhesion kinase mediates atrial fibrosis via the AKT/S6K signaling pathway in chronic atrial fibrillation patients with rheumatic mitral valve disease. Int J Cardiol. 2013; 168(4):3200-7. DOI: 10.1016/j.ijcard.2013.04.113. View

Hwang-Verslues W, Chang P, Wei P, Yang C, Huang C, Kuo W . miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1. Oncogene. 2011; 30(21):2463-74. DOI: 10.1038/onc.2010.618. View

Qi J, Liu Y, Hu K, Zhang Y, Wu Y, Zhang X . MicroRNA-26a inhibits hyperplastic scar formation by targeting Smad2. Exp Ther Med. 2018; 15(5):4332-4338. PMC: 5920963. DOI: 10.3892/etm.2018.5984. View

10.

Pfaffl M . A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29(9):e45. PMC: 55695. DOI: 10.1093/nar/29.9.e45. View

11.

Madni T, Lu K, Nakonezny P, Imran J, Cunningham H, Clark A . Treating Hypertrophic Burn Scar With 2940-nm Er:YAG Laser Fractional Ablation Improves Scar Characteristics as Measured by Noninvasive Technology. J Burn Care Res. 2019; 40(4):416-421. DOI: 10.1093/jbcr/irz056. View

12.

Li J, Chen L, Cao C, Yan H, Zhou B, Gao Y . The Long Non-Coding RNA LncRNA8975-1 is Upregulated in Hypertrophic Scar Fibroblasts and Controls Collagen Expression. Cell Physiol Biochem. 2016; 40(1-2):326-334. DOI: 10.1159/000452548. View

13.

Zhang B, Yuan F, Liu J, Li Y, Zhou F, Liu X . Hsa-miR-495 acts as a tumor suppressor gene in glioma via the negative regulation of MYB. Mol Med Rep. 2016; 14(1):977-82. DOI: 10.3892/mmr.2016.5327. View

14.

Chen R, Zhang Z, Xue Z, Wang L, Fu M, Lu Y . Focal adhesion kinase (FAK) siRNA inhibits human hypertrophic scar by suppressing integrin α, TGF-β and α-SMA. Cell Biol Int. 2014; 38(7):803-8. DOI: 10.1002/cbin.10265. View

15.

Liu C, Jian M, Qi H, Mao W . MicroRNA 495 Inhibits Proliferation and Metastasis and Promotes Apoptosis by Targeting Twist1 in Gastric Cancer Cells. Oncol Res. 2018; 27(3):389-397. PMC: 7848466. DOI: 10.3727/096504018X15223159811838. View

16.

Shi P, Xu L, Lin K, Weng W, Fang J . Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia. J Hematol Oncol. 2016; 9:12. PMC: 4757994. DOI: 10.1186/s13045-016-0241-x. View

17.

Ye Y, Zhuang J, Wang G, He S, Zhang S, Wang G . MicroRNA-495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin-like growth factor receptor-1. Exp Ther Med. 2018; 15(1):1150-1158. PMC: 5772956. DOI: 10.3892/etm.2017.5467. View

18.

He T, Bai X, Yang L, Fan L, Li Y, Su L . Loureirin B Inhibits Hypertrophic Scar Formation via Inhibition of the TGF-β1-ERK/JNK Pathway. Cell Physiol Biochem. 2015; 37(2):666-76. DOI: 10.1159/000430385. View

19.

Fu J, Jiang M, Zhang M, Zhang J, Wang Y, Xiang S . MiR-495 functions as an adjuvant to radiation therapy by reducing the radiation-induced bystander effect. Acta Biochim Biophys Sin (Shanghai). 2016; 48(11):1026-1033. DOI: 10.1093/abbs/gmw098. View

20.

Mao Y, Li L, Liu J, Wang L, Zhou Y . MiR-495 inhibits esophageal squamous cell carcinoma progression by targeting Akt1. Oncotarget. 2016; 7(32):51223-51236. PMC: 5239471. DOI: 10.18632/oncotarget.9981. View